Regulatory requirements for the authorisation of low-dose modified-release acetyl-salicylic-acid formulations in the secondary prevention of cardiovascular events

Current version

PDF iconPosition paper

Reference numberCPMP/EWP/282/02
KeywordsAcetylic salicylic acid (ASA), modified release (MR-) formulations
DescriptionThis document focuses on the requirements for approval of new low-dose oral modified release formulations of acetylic salicylic acid in the well-established indication of secondary prevention of cardiovascular events.


How useful was this page?

Add your rating